OPTIMIZER Smart System
Impulse Dynamics (Usa), Inc. · Decision date Mar 21, 2019
What did the FDA approve?
FDA approved the OPTIMIZER Smart System under PMA P180036 on March 21, 2019. The implantable pulse generator delivers Cardiac Contractility Modulation therapy and is indicated to improve 6-minute hall walk distance, quality of life, and functional status of NYHA Class III heart failure patients who remain symptomatic despite guideline directed medical therapy, who are in normal sinus rhythm, are not indicated for Cardiac Resynchronization Therapy, and have a left ventricular ejection fraction ranging from 25% to 45%.
The applicant is Impulse Dynamics (Usa), Inc., and the product code is QFV under the cardiovascular specialty. The decision record does not include supplement type or supplement reason fields, so no information is present about whether this entry reflects an original approval or a later change to an existing PMA.
FDA approval order statement
Approval for the OPTIMIZER Smart System. The device which delivers Cardiac Contractility Modulation therapy, is indicated to improve 6-minute hall walk distance, quality of life, and functional status of NYHA Class III heart failure patients who remain symptomatic despite guideline directed medical therapy, who are in normal sinus rhythm, are not indicated for Cardiac Resynchronization Therapy, and have a left ventricular ejection fraction ranging from 25% to 45%.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Mar 21, 2019
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P180036
- Regulatory pathway
- Premarket approval application
- Applicant
- Impulse Dynamics (Usa), Inc.
- Product code
- QFV
- Decision code
- APPR
- Decision date
- Mar 21, 2019
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implantable pulse generator.
- Applicant
- Impulse Dynamics (Usa), Inc.
- Product code
- QFV
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P180036 received
Application receipt date recorded by FDA.
P180036 · FDA decision
APPR
P180036/S044 · Related supplement
OPTIMIZER Smart System
P180036/S046 · Related supplement
OPTIMIZER Smart and Smart Mini System
Timeline entries are records held by MedtechLedger for P180036. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P180036
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
OPTIMIZER Smart SystemP180036/S044 | Impulse Dynamics (Usa), Inc. | PMA supplement | Sep 24, 2026 | FDA |
OPTIMIZER Smart and Smart Mini SystemP180036/S046 | Impulse Dynamics (Usa), Inc. | PMA supplement | Oct 14, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Impulse Dynamics (Usa), Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 50 Lake Center Executive Pkwy., 401 Rte. 73 N, Bldg. 50 Suite 100, Marlton, NJ, 08053
Sources and methodology
- Original FDA record: P180036
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
